Find uplifting stories about heroes, innovations, and solutions
8 results for "epidermolysis bullosa"
A four-year-old Australian boy has become the first child in the country to receive a revolutionary gene therapy for Epidermolysis Bullosa, a devastating condition that causes skin to blister at the slightest touch. The treatment is helping his body produce the critical protein his skin has been missing since birth.
John Hudson Dilgen lived with a painful genetic skin disorder that made his skin tear at the slightest touch, yet he dedicated his life to ensuring future children wouldn't suffer the same fate. His participation in clinical trials resulted in three FDA-approved treatments for Epidermolysis Bullosa, changing the lives of countless families.
Children born with epidermolysis bullosa, a painful genetic disorder causing skin to blister at the slightest touch, now have real treatment options for the first time. Three new FDA-approved therapies are healing wounds that doctors could only bandage before.
Pearl Jam's Eddie Vedder and Canadian director Matt Finlin created a documentary following the race to cure epidermolysis bullosa, a devastating skin disease affecting children worldwide. The Netflix film captures breakthrough research that could unlock treatments for thousands of rare diseases.
A rare disease nonprofit co-founded by Pearl Jam's Eddie Vedder is revolutionizing medical research by acting like a venture capital firm, turning every dollar into multiple cures. Their innovative funding model has already contributed to three FDA-approved treatments for a devastating skin disease that once had no hope.
A hospital in Indonesia built a successful rare disease registry in just two years, offering hope for similar efforts in Malaysia. The achievement could help 45 million people across Southeast Asia living with rare conditions get better care. #
Scientists at the University of British Columbia have created the first topical gene therapy that corrects faulty DNA directly in human skin, offering hope for patients with painful genetic skin disorders who currently have no cure. The breakthrough treatment could eventually help millions with conditions ranging from rare inherited diseases to common eczema.
Scientists have developed a topical treatment that corrects disease-causing genetic mutations directly in the skin, offering hope for a lasting cure to conditions previously managed for life. The breakthrough could transform treatment for rare disorders and common conditions like eczema.